What to Expect While on GLP-1 Therapy Like any medication, GLP-1 injections can cause temporary side effects, most often including mild nausea, fatigue, or digestive changes
Small changes to your diet, staying well-hydrated, and gradual dose increases can help
Loss of muscle mass is a key driver of bone density decline, as it reduces the dynamic strain on the skeleton, thereby accelerating disuse signaling
The combination hypothesis is that addressing both vascular/mucosal protection (BPC-157 territory) and cellular motility required for tissue remodeling (TB-500 territory) may produce better outcomes than either alone, though this needs study-specific verification
Saxenda (liraglutide): Manufactured by Novo Nordisk and FDA-approved for chronic weight management, Saxenda has been named in MDL 3163